Signant Health: Ian Jennings, chief commercial officer
Patient-centric trial technology provider Signant Health has named Ian Jennings chief commercial officer. He will help shape strategy and direction for the company’s commercial teams.
Mike Nolte, CEO of Signant Health, said, "Ian has a very strong background in clinical and healthcare technology with experience in eCOA, IRT, patient engagement and real-world evidence, and is a strong believer in the power of high performing teams. We believe that Ian is the perfect addition to our leadership team to guide our commercial future in 2020 and beyond.”
Jennings has approximately 30 years of commercial technology experience in the life sciences industry. He has held positions at a number of companies, including ClinPhone, Parexel Informatics, Exco InTouch and ERT.
